The new report by Expert Market Research titled, ‘Global Doxorubicin Market Analysis, Share, Price, Trends, Growth, Report and Forecast 2023-2028’, gives an in-depth analysis of the global doxorubicin market, assessing the market based on its segments like applications and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
The key highlights of the report include:
Market Overview (2018-2028)
• Forecast CAGR (2023-2028): 6.4%
The market growth has been driven by the increasing prevalence of cancer among the adults and geriatrics. According to WHO, around 2.3 million women were diagnosed with breast cancer globally in 2020. Over the forecast period, the rising healthcare expenditure in the emerging economies, coupled with the increasing health awareness, is anticipated to boost the demand for doxorubicin in the forecast period.
Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/doxorubicin-market/requestsample
In terms of region, North America accounts for a significant share in the market owing to the advanced healthcare infrastructure in the United States of America and Canada. The increasing prevalence of Leukaemia in the region is anticipated to propel the demand for the product in the forecast period.
Industry Definition and Major Segments
Doxorubicin refers to an antibiotic belonging to anthracycline class, which is obtained from a bacteria known as Streptomyces Peucetius. The mechanism of action of doxorubicin includes the formation of complexes with DNA by intercalation between base pairs. This antibiotic is used in combination with other medications to treat several types of cancers.
Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/doxorubicin-market
On the basis of application, the market can be segmented into:
• Ovarian Cancer
• Multiple Myeloma
• Kaposi Sarcoma
• Bone Sarcoma
• Breast Cancer
• Endometrial Cancer
• Gastric Cancer
• Liver Cancer
• Kidney Cancer
• Other Cancer
The regional markets for doxorubicin include:
• North America
• Asia Pacific
• Latin America
• Middle East and Africa
The key trends in the global doxorubicin market include the robust development of hospitals, ambulatory surgical centres, and nursing homes. The healthcare reimbursement policies by the government are likely to spearhead the chemotherapy procedure, thereby, boosting the demand for doxorubicin in the forecast period.
The market is anticipated to be aided by the technological advancements in the healthcare units to augment the cancer treatment procedures. Furthermore, the growing R&D activities by the major pharmaceutical companies to accelerate the production of doxorubicin are likely to provide impetus to the market in the forecast period.
Key Market Players
The major players in the market are Pfizer Inc., Sun Pharmaceutical Industries Limited, Cipla, Inc., and Cadila Pharmaceuticals Ltd., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skilful analysis and interpretation of data, the company offers its clients extensive, latest and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Ana John, Business Consultant
Toll Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA